Molecular mechanisms of vasoselectivity of the 1,4-dihydropyridine lercanidipine
Author:
Publisher
Wiley
Subject
Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0705786/fullpdf
Reference34 articles.
1. Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissues;ANGELICO;J. Pharm. Pharmacol.,1999
2. A homologous series of permanently charged 1,4-dihydropyridines: novel probes designed to localize drug binding sites on ion channels;BAINDUR;J. Med. Chem.,1993
3. L-type calcium channels: asymmetrical intramembrane binding domain revealed by variable length, permanently charged 1,4-dihydropyridines;BANGALORE;Mol. Pharmacol.,1994
4. Nitrendipine block of cardiac calcium channels: high affinity binding to the inactivated state;BEAN;Proc. Natl. Acad. Sci. U.S.A.,1984
5. The molecular mode of action of the Ca agonist (−) Bay K 8644 on the cardiac Ca channel;BECHEM;Pflügers Arch.,1993
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New Insights into the Nephroprotective Potential of Lercanidipine;International Journal of Molecular Sciences;2023-09-13
2. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19;Viruses;2021-04-09
3. Ca2+ Channel Inhibitors;Reference Module in Biomedical Sciences;2021
4. Screening of FDA-approved drugs using a MERS-CoV clinical isolate from South Korea identifies potential therapeutic options for COVID-19;2020-03-02
5. Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/β-catenin signalling pathways;Neurochemistry International;2019-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3